Device Trial Radar · NCT07158333
Mobile Cardiac Telemetry (MCT) Study
Last checked: Nov 19, 2026Latest source record: Nov 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Aug 5, 2025
Primary completion
Sep 12, 2025
Study completion Sep 12, 2025
Sponsor
- Lead sponsor
- Baxter Healthcare CorporationPublic (BAX)
- Sponsor type
- Industry
- First posted
- Sep 5, 2025
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
This study will be a single center, single arm, open-label, prospective study to evaluate adhesive performance of the Bardy Diagnostics' (BardyDx) MCT Patch up to 30 days of wear.
Conditions
- Healthy
Interventions
Mobile Cardiac Telemetry (MCT System)Device
MCT System without data transmission
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cumulative wear timeTime frame: 30 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Orange County Research Center
Lake Forest, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.